Blujepa is the first new type of oral antibiotic to treat UTIs to gain approval in more than 20 years. Its development was ...
Joining us today are Oncocyte President and CEO, Josh Riggs; Chief Science Officer, Ekke Schutz; and CFO, Andrea James. We ...
Biofrontera Inc. (NASDAQ: BFRI) Q4 2024 Earnings Call Transcript March 21, 2025 Biofrontera Inc. misses on earnings ...
Q4 2024 Earnings Conference Call March 24, 2025 5:00 PM ETCompany ParticipantsGabby Woody - Executive Assistant, ...
Sara Gran — whose 2003 novel of demonic possession, “Come Closer,” is a cult favorite — recommends her favorites.
Pope Francis appeared in public on Sunday for the first time since his hospital stay began, which lasted more than five weeks ...
Through their mutual aid partners, OPPD is getting that help from nearly 300 additional workers. Many of them are from out of ...
Sera Prognostics Inc ( NASDAQ: SERA) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director Austin Aerts - CFO ...
Patient experience leader Jennifer Carron explains why healthcare lags in customer experience and how real-time feedback is ...
2025 is finally upon us and the trends for healthcare marketers continue to evolve.
A recording of President Trump’s private remarks at a Kennedy Center board meeting shows that he mused about bestowing honors ...
NFL Draft on tap in April, Maurice Jones-Drew takes a look at this year's spectacularly deep running back class, ranking the ...